Financial Performance Highlights

Consolidated Financial Results (₹ crore):

Q4 FY26 Performance:

  • Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4FY25
  • Gross Profit: ₹210.4 crore, up 17.0% YoY from ₹179.8 crore
  • Gross Margin: 46.7% vs 45.8% in Q4FY25
  • EBITDA: ₹76.7 crore, up 19.7% YoY from ₹64.1 crore
  • EBITDA Margin: 17.0% vs 16.3% in Q4FY25
  • PAT: ₹43.4 crore, up 11.5% YoY from ₹38.9 crore
  • PAT Margin: 9.6% vs 9.9% in Q4FY25

Full Year FY26 Performance:

  • Operating Revenues: ₹1,609.7 crore, up 11.3% YoY from ₹1,446.5 crore in FY25
  • Gross Profit: ₹725.6 crore, up 11.3% YoY from ₹651.7 crore
  • Gross Margin: 45.1% (unchanged from FY25)
  • EBITDA: ₹252.4 crore, up 10.5% YoY from ₹228.4 crore
  • EBITDA Margin: 15.7% vs 15.8% in FY25
  • PAT: ₹142.2 crore, up 12.3% YoY from ₹126.6 crore
  • PAT Margin: 8.8% (unchanged from FY25)

Balance Sheet & Financial Metrics

  • ROCE: 16.3%
  • Debt-to-Equity Ratio: 0.49x
  • Current Ratio: 1.6x
  • Credit Rating: CARE A– (Long Term) | CARE A2+ (Short Term)
  • Market Capitalization: ₹3,898.22 crore (as of May 30, 2026)
  • Shares Outstanding: 6.73 crore

Growth Catalysts & Strategic Updates

Backward Integration:

  • Acquisition completed with integration underway
  • Phased production to start from H2FY26 onwards
  • Ensures raw material security

Strontium Business:

  • Commercialized in FY26 as import substitute
  • Customer approvals progressing positively
  • Better capacity utilization expected in FY27

Speciality Chemicals Expansion:

  • New range of high-value speciality chemicals and derivatives
  • Applications in pharmaceuticals, agrochemicals, electronics, and emerging applications
  • Leverages existing capabilities and R&D

Dividend History

Consistent dividend track record:

  • FY22: ₹2.00 per share (20% payout)
  • FY23: ₹0.40 per share (20% payout)
  • FY24: ₹0.30 per share (15% payout)
  • FY25: ₹0.30 per share (15% payout)
  • FY26: ₹0.30 per share proposed (15% payout, subject to shareholder approval)

Company Overview

  • 35+ years of manufacturing legacy
  • Multi-locational manufacturing excellence with close proximity to ports
  • Exports to 50+ countries
  • Products include Sodium Dichromate, Basic Chrome Sulphate, Chromic Acid, Chrome Oxide Green, Potassium Dichromate, White Sodium Sulphate, Barium Carbonate, Precipitated Barium Sulphate, Sodium Sulphide, Strontium Carbonate
  • Applications across pharmaceuticals, tanning, pigments & dyes, automobiles, electroplating, timber treatment, refractory, ceramics & tiles, plastic masterbatches, matches, photographic engraving, artificial sweeteners, paper, detergents, molten glass, brine purification, speciality glass, bricks, paints, battery, plastics, water treatment, magnets, electronics, metallurgy

Leadership Perspective

Siddartha Cherukuri, Jt. Managing Director, and Krishna Murthy Cherukuri, Chairman & Managing Director, expressed gratitude for achieving ₹1,600 crore revenue milestone and emphasized focus on nurturing complex chemistries, delivering high-quality products with global cost competitiveness, manufacturing excellence, execution discipline, and long-term thinking for sustainable value creation.

ESG & Community Commitment

  • Commitment to ESG principles
  • Focus on health & safety
  • Community initiatives including old age home support, plantation, rural health care
  • Focus on waste reduction, recycling, and reuse
  • Emphasis on empowerment and socio-economic welfare of the community